Investigational device for patients with non-valvular afib

Trial ID:
IRB-21-7812
Matthew J Price, M.D.
This trial is evaluating the safety and effectiveness of the Amulet device compare to NOAC (non-vitamin K antagonist oral anticoagulants) therapy in patients with non-valvular atrial fibrillation (Afib) at increased risk for ischemic stroke and who are recommended for long tern NOAC therapy.

Inclusion Criteria

Patients must:

  • Be at high risk of stroke or systemic embolism, defined as a CHA2DS2-VASc score of = 3
    Be eligible for long-term NOAC therapy
    Be 18 years of age or older
    Meet all other eligibility criteria

Exclusion Criteria

Patients must not:

  • Require long-term OAC therapy for a condition other than afib
    Have a history of rheumatic or congenital mitral valve heart disease

Additional Info

All treatments and physician visits during this study will take place at Scripps Clinic Anderson Medical Pavilion.

For more information, search for NCT# 04226547 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org